cilostazol has been researched along with Idiopathic Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sayed, RM | 1 |
| Abdelaziz, AM | 1 |
| Zaki, HF | 1 |
| Abdel Rasheed, NO | 1 |
| Hedya, SA | 1 |
| Safar, MM | 1 |
| Bahgat, AK | 1 |
2 other studies available for cilostazol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR signaling.
Topics: Animals; Cilostazol; HMGB1 Protein; Mammals; Neuroprotection; Neuroprotective Agents; NF-E2-Related | 2023 |
Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model.
Topics: Animals; Apoptosis; Autophagy; Behavior, Animal; Biomarkers; Cilostazol; Disease Models, Animal; Gly | 2018 |